Sharekhan

#SharekhanResearch retains Buy on #Cadila (PT Rs560) #Q3FY22 was steady qtr; Strng gwth outlook for India & Emergin… https://t.co/KxwLn7pZg9 #SharekhanResearch #Cadila #Q3FY22

#SharekhanFNA #SharekhanResearch retains Buy on #Cadila (PT Rs720) India bizz on a strong footing to stage a double… https://t.co/p7fQwP0Ohw #SharekhanFNA #SharekhanResearch #Cadila

#SharekhanResearch retains Buy rating on #Cadila (PT Rs 720) reports healthy performance for #Q1FY22; Strong growth… https://t.co/gtZyYOCd4n #SharekhanResearch #Cadila #Q1FY22

#SharekhanFNA #SharekhanResearch retains Buy rating on #Cadila (PT Rs 720) reports healthy performance for #Q4FY21;… https://t.co/Ej3k7bZEUj #SharekhanFNA #SharekhanResearch #Cadila #Q4FY21

#SharekhanFNA #Cadila announces the successful completion of phase I/II clinical trials of its Covid19 vaccine -… https://t.co/46B6DPgnTb #SharekhanFNA #Cadila